Breadcrumb

What's New at the RI-MUHC ?

RI-MUHC and McGill awarded $5.1 million for infectious disease research

A new grant from the Canada Foundation for Innovation will invest in leading edge Containment Level 3...

Helping young adults achieve type 2 diabetes remission

In a collaboration with British researchers, Dr. Kaberi Dasgupta is leading a clinical trial that combines supervised exercise with meal...

The 2022 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

Quebec study on long COVID seeking participants

Purpose is to understand post-COVID symptom evolution and impact on patients’ lives

Big start for the Canadian Mother-Child Collaborative Training Platform – CAMCCO-L

CAMCCO-L is the first Canadian platform for interdisciplinary training in perinatal research on medications...

Perception is everything when it comes to the heart

McGill startup is developing an innovative mixed reality platform to support surgeons

Early and mid-career scientists at the RI-MUHC launch an organization for professional support

The newly created EArly and mid-CAreer REsearchers network (EACARE) will promote networking...

Parasitic worms reprogram intestinal stem cells to evade the immune system

A new collaboration between immunoparasitologists and stem cell biologists at the RI-MUHC describes...

A first large detailed description of the worldwide 2022 monkeypox outbreak

MUHC physicians made important contributions to a new article published in the New England Journal of Medicine

RI-MUHC study shows association of low muscle mass with cognitive decline

A new publication in JAMA Network Open describes faster decline in cognitive executive function in older adults with...

Learn more about the RI-MUHC